Trial · NCT02487979
Results by group35
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 35
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Disease Control Success | Treatment (Glembatumumab Vedotin) | 3 | Participants | ||
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Abdominal Pain | 2 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of acneiform rash | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Anaphylaxis | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Anemia | 2 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Anorexia | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Back Pain | 2 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Constipation | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Febrile Neutropenia | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Headache | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Hypertension | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Hypocalcemia | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Hypokalemia | 4 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Hypophosphatemia | 2 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Hypotension | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Leukopenia | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Lymphopenia | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Mucocitis | 2 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Myalgia | 1 | cycles | |
| Toxicity Associated With Chemotherapy | Treatment (Glembatumumab Vedotin) | Incidence of Nausea | 1 | cycles |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02487979/results